Katrina Perehudoff

Dr. Katrina Perehudoff


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Clinical Interventions in Aging
Verified
Journal Article
Open access
ASAnnemie Somers
Annemie Somers
HRHugo Robays
Hugo Robays
PPPeter De Paepe
Peter De Paepe
GMGeorges Van Maele
Georges Van Maele
KPKatrina Perehudoff
Katrina Perehudoff
MPMirko Petrovic
Mirko Petrovic
Peer reviewed article authored by (Somers A, Robays H, De Paepe P, Van Maele G, Perehudoff K, Petrovic M). Read article or submit your manuscript for publishing.

28 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KPKatrina Perehudoff
Katrina Perehudoff
NANikita Alexandrov
Nikita Alexandrov
HHHans V. Hogerzeil
Hans V. Hogerzeil
Persistent barriers to universal access to medicines are limited social protection in the event of illness, inadequate financing for essential medicines, frequent stock-outs in the public sector, and high prices in the private sector. We argue that greater coherence between human rights law, national medicines policies, and universal health coverage schemes can address these barriers. We present a cross-national content analysis of national medicines policies from 71 countries published between 1990–2016. The World Health Organization’s (WHO) 2001 guidelines for developing and implementing a national medicines policy and all 71 national medicines policies were assessed on 12 principles, linking a health systems approach to essential medicines with international human rights law for medicines affordability and financing for vulnerable groups. National medicines policies most frequently contain measures for medicines selection and efficient spending/cost-effectiveness. Four principles (legal right to health; government financing; efficient spending; and financial protection of vulnerable populations) are significantly stronger in national medicines policies published after 2004 than before. Six principles have remained weak or absent: pooling user contributions, international cooperation, and four principles for good governance. Overall, South Africa (1996), Indonesia and South Sudan (2006), Philippines (2011–2016), Malaysia (2012), Somalia (2013), Afghanistan (2014), and Uganda (2015) include the most relevant texts and can be used as models for other settings. We conclude that WHO’s 2001 guidelines have guided the content and language of many subsequent national medicines policies. WHO and national policy makers can use these principles and the practical examples identified in our study to further align national medicines policies with human rights law and with Target 3.8 for universal access to essential medicines in the Sustainable Development Goals.

2 November 2020 in Global Health Action
Verified
Journal Article
Open access
KPKatrina Perehudoff
Katrina Perehudoff
Access to essential medicines for the world’s poor and vulnerable has made little progress since 2000, except for a few specific medicines such as antiretrovirals for HIV/AIDS. Human rights princip...

14 July 2022 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
KPKatrina Perehudoff
Katrina Perehudoff
EHEllen 'T Hoen
Ellen 'T Hoen
KMKaitlin Mara
Kaitlin Mara
TBThirukumaran Balasubramaniam
Thirukumaran Balasubramaniam
FAFrederick Abbott
Frederick Abbott
JLJames Love
James Love

24 October 2017 in Therapeutic Advances in Drug Safety
Verified
Journal Article
Open access
PDF file
ALAmanda Lavan
Amanda Lavan
JEJoseph Eustace
Joseph Eustace
DDDarren Dahly
Darren Dahly
EFEvelyn Flanagan
Evelyn Flanagan
PGPaul Gallagher
Paul Gallagher
DODenis O'Mahony
Denis O'Mahony
Background: Adverse drug reactions (ADRs) are common in older adults and frequently have serious clinical and economic consequences. This study was conducted as a feasibility study for a randomized control trial (RCT) that will investigate the efficacy of a software engine to optimize medications and reduce incident (in-hospital) ADRs. This study’s objectives were to (i) establish current incident ADR rates across the six sites participating in the forthcoming RCT and (ii) assess whether incident ADRs are predictable. Methods: This was a multicentre, prospective observational study involving six European hospitals. Adults aged ⩾ 65 years, hospitalized with an acute illness and on pharmacological treatment for three or more conditions were eligible for inclusion. Adverse events (AEs) were captured using a trigger list of 12 common ADRs. An AE was deemed an ADR when its association with an administered drug was adjudicated as being probable/certain, according to the World Health Organization Uppsala Monitoring Centre causality assessment. The proportion of patients experiencing at least one, probable/certain, incident ADR within 14 days of enrolment/discharge was recorded. Results: A total of 644 patients were recruited, evenly split by sex and overwhelmingly of White ethnicity. Over 80% of admissions were medical. The median number of chronic conditions was five (interquartile range 4–6), with eight or more conditions present in approximately 10%. The mean number of prescribed medications was 9.9 (standard deviation 3.8), which correlated strongly with the number of conditions ( r = 0.54, p < 0.0001). A total of 732 AEs were recorded in 382 patients, of which 363 were incident. The majority of events were classified as probably or possibly drug related, with heterogeneity across sites (χ2 = 88.567, df = 20, p value < 0.001). Out of 644 patients, 139 (21.6%; 95% confidence interval 18.5–25.0%) experienced an ADR. Serum electrolyte abnormalities were the most common ADR. The ADRROP (ADR Risk in Older People) and GerontoNet ADR risk scales correctly predicted ADR occurrence in 61% and 60% of patients, respectively. Conclusion: This feasibility study established the rates of incident ADRs across the six study sites. The ADR predictive power of ADRROP and GerontoNet ADR risk scales were limited in this population.

29 September 2020 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
ASAli Ssetaala
Ali Ssetaala
JNJoan Nabawanuka
Joan Nabawanuka
GMGideon Matovu
Gideon Matovu
NNNusula Nakiragga
Nusula Nakiragga
JNJudith Namugga
Judith Namugga
ODOlivier Degomme
Olivier Degomme
Background: Uganda has one of the highest maternal deaths at a ratio of 336 per 100,000 live births. As Uganda strives to achieve sustainable development goals, appropriate antenatal care is key to reduction of maternal mortality. We explored women’s reported receipt of seven of the Uganda guidelines components of antenatal care, and associated factors in hard to reach Lake Victoria island fishing communities of Kalangala district. Methods: A cross sectional survey among 486 consenting women aged 15–49 years, who were pregnant at any time in the past 6 months was conducted in 6 island fishing communities of Kalangala district, Uganda, during January–May 2018. Interviewer administered questionnaires, were used to collect data on socio-demographics and receipt of seven of the Uganda guidelines components of antenatal care. Regression modeling was used to determine factors associated with receipt of all seven components. Results: Over three fifths (65.0%) had at least one ANC visit during current or most recent pregnancy. Fewer than a quarter of women who reported attending care at least four times received all seven ANC components [(23.6%), P < 0.05]. Women who reported receipt of ANC from the mainland were twice as likely to have received all seven components as those who received care from islands (aOR = 1.8; 95% CI:0.9–3.7). Receipt of care from a doctor was associated with thrice likelihood of receiving all components relative to ANC by a midwife or nurse (aOR = 3.2; 95% CI:1.1–9.1). Conclusions: We observed that the delivery of antenatal care components per Ugandan guidelines is poor in these communities. Cost effective endeavors to improve components of antenatal care received by women are urgently needed. Task shifting some components of ANC to community health workers may improve care in these island communities. Trial registration: PACTR201903906459874 (Retrospectively registered).